Molecular Signatures Predict Problematic Lung Lesions.
According to a recent study, lung carcinoma in situ lesions that develop into invasive tumors have a molecular signature distinct from those that spontaneously regress. These findings may aid in the development of a test to identify high-risk tumors that require therapeutic intervention.